Lupin Limited (LUPIN) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.147x

Based on the latest financial reports, Lupin Limited (LUPIN) has a cash flow conversion efficiency ratio of 0.147x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs29.03 Billion ≈ $313.93 Million USD) by net assets (Rs197.28 Billion ≈ $2.13 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Lupin Limited market cap and net worth for the company's overall valuation and market capitalisation.

Lupin Limited - Cash Flow Conversion Efficiency Trend (2004–2026)

This chart illustrates how Lupin Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Lupin Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Lupin Limited ranked by their cash flow conversion efficiency. Explore Lupin Limited earnings quality ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
BALOISE HLDG AG ADR/1/10
F:BLO
N/A
Eurofins Scientific SE
PA:ERF
0.220x
The AES Corporation
NYSE:AES
0.128x
SK TELECOM CO.LTD.ADR 5/9
F:KMBA
0.085x
Camden Property Trust
NYSE:CPT
0.036x
China Pacific Insurance (Group) Co. Ltd
F:75C
0.102x
Mankind Pharma Ltd
NSE:MANKIND
0.099x
Shenzhen Megmeet Electrical Co Ltd
SHE:002851
-0.010x

Annual Cash Flow Conversion Efficiency for Lupin Limited (2004–2026)

The table below shows the annual cash flow conversion efficiency of Lupin Limited from 2004 to 2026. View LUPIN stock price and chart for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs225.13 Billion
≈ $2.43 Billion
Rs71.90 Billion
≈ $777.56 Million
0.319x +84.11%
2025-03-31 Rs172.94 Billion
≈ $1.87 Billion
Rs30.00 Billion
≈ $324.43 Million
0.173x -31.66%
2024-03-31 Rs143.73 Billion
≈ $1.55 Billion
Rs36.48 Billion
≈ $394.56 Million
0.254x +67.83%
2023-03-31 Rs125.43 Billion
≈ $1.36 Billion
Rs18.97 Billion
≈ $205.15 Million
0.151x +403.24%
2022-03-31 Rs122.22 Billion
≈ $1.32 Billion
Rs3.67 Billion
≈ $39.72 Million
0.030x -77.14%
2021-03-31 Rs138.58 Billion
≈ $1.50 Billion
Rs18.22 Billion
≈ $197.02 Million
0.131x +12.60%
2020-03-31 Rs125.81 Billion
≈ $1.36 Billion
Rs14.69 Billion
≈ $158.85 Million
0.117x -3.37%
2019-03-31 Rs137.89 Billion
≈ $1.49 Billion
Rs16.66 Billion
≈ $180.17 Million
0.121x -6.05%
2018-03-31 Rs136.17 Billion
≈ $1.47 Billion
Rs17.51 Billion
≈ $189.38 Million
0.129x -57.69%
2017-03-31 Rs135.32 Billion
≈ $1.46 Billion
Rs41.14 Billion
≈ $444.86 Million
0.304x +1022.36%
2016-03-31 Rs111.95 Billion
≈ $1.21 Billion
Rs-3.69 Billion
≈ $-39.90 Million
-0.033x -110.73%
2015-03-31 Rs88.98 Billion
≈ $962.30 Million
Rs27.33 Billion
≈ $295.57 Million
0.307x +7.27%
2014-03-31 Rs69.99 Billion
≈ $756.86 Million
Rs20.04 Billion
≈ $216.72 Million
0.286x +20.48%
2013-03-31 Rs52.64 Billion
≈ $569.24 Million
Rs12.51 Billion
≈ $135.29 Million
0.238x +73.36%
2012-03-31 Rs40.85 Billion
≈ $441.80 Million
Rs5.60 Billion
≈ $60.57 Million
0.137x -42.67%
2011-03-31 Rs33.33 Billion
≈ $360.41 Million
Rs7.97 Billion
≈ $86.18 Million
0.239x -8.32%
2010-03-31 Rs25.93 Billion
≈ $280.46 Million
Rs6.76 Billion
≈ $73.15 Million
0.261x -20.06%
2009-03-31 Rs14.39 Billion
≈ $155.63 Million
Rs4.70 Billion
≈ $50.78 Million
0.326x +62.70%
2008-03-31 Rs12.89 Billion
≈ $139.41 Million
Rs2.59 Billion
≈ $27.96 Million
0.201x -1.57%
2007-03-31 Rs8.73 Billion
≈ $94.45 Million
Rs1.78 Billion
≈ $19.24 Million
0.204x -8.77%
2006-03-31 Rs5.89 Billion
≈ $63.68 Million
Rs1.32 Billion
≈ $14.22 Million
0.223x +18.37%
2005-03-31 Rs4.91 Billion
≈ $53.05 Million
Rs925.60 Million
≈ $10.01 Million
0.189x -79.18%
2004-03-31 Rs4.32 Billion
≈ $46.67 Million
Rs3.91 Billion
≈ $42.29 Million
0.906x --

About Lupin Limited

NSE:LUPIN India Drug Manufacturers - Specialty & Generic
Market Cap
$10.20 Billion
Rs943.37 Billion INR
Market Cap Rank
#2194 Global
#92 in India
Share Price
Rs2063.20
Change (1 day)
-1.52%
52-Week Range
Rs1905.60 - Rs2514.80
All Time High
Rs2514.80
About

Lupin Limited, together with its subsidiaries, operates as a pharmaceutical company in India, the United States, and internationally. The company operates in two segments: Pharmaceuticals and Others. It produces, develops, and markets various branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs). The company also offers products in the therapeutic … Read more